FDA Inspection
ADMA Biologics, IncADMA Biologics, Inc – FDA Inspection, Dec 11, 2024
Record Details
This FDA Inspection record concerns ADMA Biologics, Inc, with an inspection on December 11, 2024, issued by the Florida District Office, covering biologics.
View Company Profile
ID · 81f31913-5145-4320-88eb-71fd5f3425fc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1256275
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ADMA Biologics, Inc
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2023 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| August 12, 2021 | VAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 12, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 3, 2016 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 14, 2014 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ADMA Biologics, Inc
- FDA Inspection 1219342 - 2023-09-20
- FDA Inspection 1150114 - 2021-08-12
- FDA Inspection 1049629 - 2018-04-12
- FDA Inspection 974061 - 2016-03-03
- FDA Inspection 892829 - 2014-08-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.